Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Progestogen for preventing miscarriage

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD003511.pub3Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 31 octubre 2013see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Embarazo y parto

Copyright:
  1. Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • David M Haas

    Correspondencia a: Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, USA

    [email protected]

  • Patrick S Ramsey

    Division of Maternal‐Fetal Medicine, Department of Obstetrics and Gynecology, Uniformed Services University of Health Sciences, Bethesda, USA

Contributions of authors

David Haas: is the guarantor of the review; prepared the 2013 update; performed independent data extraction and quality assessment of the included trials, and commented on all drafts of the review.

Patrick Ramsey: performed independent data extraction and quality assessment of included trials for the updates; commented on the drafts for this update.

Declarations of interest

None known related to the review topic. A portion of Dr Haas's time and effort are supported by a grant from the US National Institutes of Health Obstetric‐Fetal Pharmacology Units research network grant #5U10HD063094.

Acknowledgements

The review authors would like to thank Lynn Hampson for her search of the Cochrane Pregnancy and Childbirth Group's Trials Register.

The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Pregnancy and Childbirth Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, NHS or the Department of Health.

Version history

Published

Title

Stage

Authors

Version

2019 Nov 20

Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology

Review

David M Haas, Taylor J Hathaway, Patrick S Ramsey

https://doi.org/10.1002/14651858.CD003511.pub5

2018 Oct 09

Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology

Review

David M Haas, Taylor J Hathaway, Patrick S Ramsey

https://doi.org/10.1002/14651858.CD003511.pub4

2013 Oct 31

Progestogen for preventing miscarriage

Review

David M Haas, Patrick S Ramsey

https://doi.org/10.1002/14651858.CD003511.pub3

2008 Apr 23

Progestogen for preventing miscarriage

Review

David M Haas, Patrick S Ramsey

https://doi.org/10.1002/14651858.CD003511.pub2

2003 Oct 20

Progestogen for preventing miscarriage

Review

R M Oates‐Whitehead, David M Haas, J AK Carrier

https://doi.org/10.1002/14651858.CD003511

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Funnel plot of comparison: 1 Progestogen versus placebo/no treatment, outcome: 1.1 Miscarriage (all trials).
Figuras y tablas -
Figure 1

Funnel plot of comparison: 1 Progestogen versus placebo/no treatment, outcome: 1.1 Miscarriage (all trials).

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 2

'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 3

'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.

Comparison 1 Progestogen versus placebo/no treatment, Outcome 1 Miscarriage (all trials).
Figuras y tablas -
Analysis 1.1

Comparison 1 Progestogen versus placebo/no treatment, Outcome 1 Miscarriage (all trials).

Comparison 1 Progestogen versus placebo/no treatment, Outcome 2 Miscarriage (placebo controlled trials only).
Figuras y tablas -
Analysis 1.2

Comparison 1 Progestogen versus placebo/no treatment, Outcome 2 Miscarriage (placebo controlled trials only).

Comparison 1 Progestogen versus placebo/no treatment, Outcome 3 Miscarriage (women with previous recurrent miscarriage only).
Figuras y tablas -
Analysis 1.3

Comparison 1 Progestogen versus placebo/no treatment, Outcome 3 Miscarriage (women with previous recurrent miscarriage only).

Comparison 1 Progestogen versus placebo/no treatment, Outcome 4 Miscarriage (by route of administration versus placebo).
Figuras y tablas -
Analysis 1.4

Comparison 1 Progestogen versus placebo/no treatment, Outcome 4 Miscarriage (by route of administration versus placebo).

Comparison 1 Progestogen versus placebo/no treatment, Outcome 5 Preterm birth.
Figuras y tablas -
Analysis 1.5

Comparison 1 Progestogen versus placebo/no treatment, Outcome 5 Preterm birth.

Comparison 1 Progestogen versus placebo/no treatment, Outcome 6 Neonatal death.
Figuras y tablas -
Analysis 1.6

Comparison 1 Progestogen versus placebo/no treatment, Outcome 6 Neonatal death.

Comparison 1 Progestogen versus placebo/no treatment, Outcome 7 Fetal genital abnormalities/virilisation.
Figuras y tablas -
Analysis 1.7

Comparison 1 Progestogen versus placebo/no treatment, Outcome 7 Fetal genital abnormalities/virilisation.

Comparison 1. Progestogen versus placebo/no treatment

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Miscarriage (all trials) Show forest plot

14

2158

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.99 [0.78, 1.24]

2 Miscarriage (placebo controlled trials only) Show forest plot

14

2158

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.99 [0.78, 1.24]

2.1 Trials with placebo control group

10

1028

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.15 [0.88, 1.50]

2.2 Trials without placebo controls

4

1130

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.65 [0.42, 1.02]

3 Miscarriage (women with previous recurrent miscarriage only) Show forest plot

10

1287

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.84 [0.66, 1.07]

3.1 Women with a history of 3 or more prior miscarriages

4

225

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.39 [0.21, 0.72]

3.2 Women with a history of 2 or more prior miscarriage

7

450

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.68 [0.43, 1.07]

3.3 Women with unspecified prior miscarriages presenting with threatened miscarriage

3

612

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.17 [0.84, 1.63]

4 Miscarriage (by route of administration versus placebo) Show forest plot

11

1600

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.87 [0.65, 1.17]

4.1 Oral versus placebo/control

5

517

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.96 [0.65, 1.40]

4.2 Intramuscular versus placebo/control

4

728

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.77 [0.36, 1.68]

4.3 Vaginal versus placebo/control

2

355

Peto Odds Ratio (Peto, Fixed, 95% CI)

0.74 [0.40, 1.35]

5 Preterm birth Show forest plot

7

946

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.10 [0.67, 1.81]

6 Neonatal death Show forest plot

5

445

Peto Odds Ratio (Peto, Fixed, 95% CI)

1.38 [0.72, 2.64]

7 Fetal genital abnormalities/virilisation Show forest plot

4

228

Peto Odds Ratio (Peto, Fixed, 95% CI)

7.64 [0.15, 385.21]

Figuras y tablas -
Comparison 1. Progestogen versus placebo/no treatment